
MEDINET Co., Ltd. — Investor Relations & Filings
MEDINET Co., Ltd. is a Contract Development and Manufacturing Organization (CDMO) specializing in regenerative medicine and cell therapy. The company provides comprehensive, one-stop solutions across the entire value chain, from pre-clinical research and process development to manufacturing and commercial launch. Its services encompass technology transfer, quality control, and quality assurance for regenerative medical products, investigational products, and specified cell products. MEDINET operates an advanced cell processing facility (CPF) designed to comply with international standards such as GCTP, leveraging extensive experience since 1999 to support clients in developing and manufacturing their cellular therapies.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 確認書 | 2026-05-14 | Japanese | |
| 半期報告書-第31期(2025/10/01-2026/09/30) | 2026-05-14 | Japanese | |
| 第三者割当による第20回新株予約権(行使価額修正条項付)の月間行使状況に関するお知らせ | 2026-05-01 | Japanese | |
| 訂正有価証券届出書(参照方式) | 2025-12-17 | Japanese | |
| 確認書 | 2025-12-17 | Japanese | |
| 有価証券報告書-第30期(2024/10/01-2025/09/30) | 2025-12-17 | Japanese |
Browse filings by year
12 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
3 filings
| |||||
| 45847409 | 確認書 | 2026-05-14 | Japanese | ||
| 45847278 | 半期報告書-第31期(2025/10/01-2026/09/30) | 2026-05-14 | Japanese | ||
| 46880658 | 第三者割当による第20回新株予約権(行使価額修正条項付)の月間行使状況に関するお知らせ | 2026-05-01 | Japanese | ||
|
2025
7 filings
| |||||
| 10216473 | 訂正有価証券届出書(参照方式) | 2025-12-17 | Japanese | ||
| 10212800 | 確認書 | 2025-12-17 | Japanese | ||
| 10212778 | 有価証券報告書-第30期(2024/10/01-2025/09/30) | 2025-12-17 | Japanese | ||
| 9323969 | 訂正有価証券届出書(参照方式) | 2025-12-05 | Japanese | ||
| 9129937 | 有価証券届出書(参照方式) | 2025-12-03 | Japanese | ||
| 7263935 | 確認書 | 2025-05-14 | Japanese | ||
| 7263938 | 半期報告書-第30期(2024/10/01-2025/09/30) | 2025-05-14 | Japanese | ||
|
2024
5 filings
| |||||
| 7290023 | 臨時報告書 | 2024-12-26 | Japanese | ||
| 7291607 | 確認書 | 2024-12-18 | Japanese | ||
| 7291598 | 内部統制報告書-第29期(2023/10/01-2024/09/30) | 2024-12-18 | Japanese | ||
| 7291599 | 有価証券報告書-第29期(2023/10/01-2024/09/30) | 2024-12-18 | Japanese | ||
| 7338102 | 確認書 | 2024-05-14 | Japanese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AC Immune SA
Biopharmaceutical firm developing precision medicine for ne…
|
ACIU | CH | Manufacturing |
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
MEDINET Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/13339/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=13339 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=13339 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=13339 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 13339}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for MEDINET Co., Ltd. (id: 13339)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.